A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
172
50

Histologic classification of ductal carcinoma in situ.
Shabnam Jaffer, Ira J Bleiweiss. Microsc Res Tech 2002
24
50

pROC: an open-source package for R and S+ to analyze and compare ROC curves.
Xavier Robin, Natacha Turck, Alexandre Hainard, Natalia Tiberti, Frédérique Lisacek, Jean-Charles Sanchez, Markus Müller. BMC Bioinformatics 2011
50

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.
Mary F Dillon, Enda W McDermott, Cecily M Quinn, Ann O'Doherty, Niall O'Higgins, Arnold D K Hill. J Surg Oncol 2006
70
50


The LORIS Trial: Addressing overtreatment of ductal carcinoma in situ.
A Francis, L Fallowfield, D Rea. Clin Oncol (R Coll Radiol) 2015
53
50

National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.
Carmen J Allegra, Denise R Aberle, Pamela Ganschow, Stephen M Hahn, Clara N Lee, Sandra Millon-Underwood, Malcolm C Pike, Susan D Reed, Audrey F Saftlas, Susan A Scarvalone,[...]. J Natl Cancer Inst 2010
149
50

DCIS of the breast: The value of preoperative MRI.
Anthony James Doyle, Sharath Prakash, Kaye Wang, Isaac Cranshaw, Eletha Taylor, Robyn Oldfield. J Med Imaging Radiat Oncol 2016
7
50

Predicting invasion in mammographically detected microcalcification.
M J Bagnall, A J Evans, A R Wilson, S E Pinder, H Denley, J G Geraghty, I O Ellis. Clin Radiol 2001
51
50

Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and Technologies.
Mohamed I Nounou, Fatema ElAmrawy, Nada Ahmed, Kamilia Abdelraouf, Satyanarayana Goda, Hussaini Syed-Sha-Qhattal. Breast Cancer (Auckl) 2015
87
50

Ductal Carcinoma In Situ: Treatment Update and Current Trends.
Katrina B Mitchell, Henry Kuerer. Curr Oncol Rep 2015
19
50

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
53
50

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
22
50

Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Chih-Wei Lee, Hwa-Koon Wu, Hung-Wen Lai, Wen-Pei Wu, Shou-Tung Chen, Dar-Ren Chen, Chih-Jung Chen, Shou-Jen Kuo. Eur J Radiol 2016
26
50

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
364
50

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
206
50

Advances in novel drug delivery strategies for breast cancer therapy.
Ritu Dhankhar, Suresh P Vyas, Arvind K Jain, Sahil Arora, Goutam Rath, Amit K Goyal. Artif Cells Blood Substit Immobil Biotechnol 2010
45
50

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).
E Shelley Hwang, Terry Hyslop, Thomas Lynch, Elizabeth Frank, Donna Pinto, Desiree Basila, Deborah Collyar, Antonia Bennett, Celia Kaplan, Shoshana Rosenberg,[...]. BMJ Open 2019
79
50

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
Michael R Harowicz, Ashirbani Saha, Lars J Grimm, P Kelly Marcom, Jeffrey R Marks, E Shelley Hwang, Maciej A Mazurowski. J Magn Reson Imaging 2017
10
50


Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Bibo Shi, Lars J Grimm, Maciej A Mazurowski, Jay A Baker, Jeffrey R Marks, Lorraine M King, Carlo C Maley, E Shelley Hwang, Joseph Y Lo. Acad Radiol 2017
11
50

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
40
50

Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme.
Y T Sim, J Litherland, E Lindsay, P Hendry, K Brauer, H Dobson, C Cordiner, T Gagliardi, L Smart. Clin Radiol 2015
12
50

Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Armando E Giuliano, James L Connolly, Stephen B Edge, Elizabeth A Mittendorf, Hope S Rugo, Lawrence J Solin, Donald L Weaver, David J Winchester, Gabriel N Hortobagyi. CA Cancer J Clin 2017
335
50

Prioritization of research addressing management strategies for ductal carcinoma in situ.
Jennifer M Gierisch, Evan R Myers, Kristine M Schmit, Matthew J Crowley, Douglas C McCrory, Ranee Chatterjee, Remy R Coeytaux, Amy Kendrick, Gillian D Sanders. Ann Intern Med 2014
25
50

Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials.
Lars J Grimm, Marc D Ryser, Ann H Partridge, Alastair M Thompson, Jeremy S Thomas, Jelle Wesseling, E Shelley Hwang. Ann Surg Oncol 2017
39
50


Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?
C H Lee, D Carter, L E Philpotts, M E Couce, L J Horvath, R C Lange, I Tocino. Radiology 2000
109
50

Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.
Bibo Shi, Lars J Grimm, Maciej A Mazurowski, Jay A Baker, Jeffrey R Marks, Lorraine M King, Carlo C Maley, E Shelley Hwang, Joseph Y Lo. J Am Coll Radiol 2018
28
50

Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.
Randy Yeh, Yu-Kwang Donovan Tay, Gaia Tabacco, Laurent Dercle, Jennifer H Kuo, Leonardo Bandeira, Catherine McManus, David K Leung, James A Lee, John P Bilezikian. Radiology 2019
42
50

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study.
Takahisa Hiramitsu, Toshihide Tomosugi, Manabu Okada, Kenta Futamura, Makoto Tsujita, Norihiko Goto, Shunji Narumi, Yoshihiko Watarai, Yoshihiro Tominaga, Toshihiro Ichimori. Sci Rep 2019
5
50


Tc 99m Sestamibi Scanning in Multiple Myeloma--a New look with SPECT-CT.
Karuna Luthra, Abhay Bhave, R D Lele. J Assoc Physicians India 2014
6
50

Paraneoplastic syndromes in prostate cancer.
Matthew K Hong, Jennifer Kong, Benjamin Namdarian, Anthony Longano, Jeremy Grummet, Christopher M Hovens, Anthony J Costello, Niall M Corcoran. Nat Rev Urol 2010
30
50

Tc-99m sestamibi uptake in metastatic prostate carcinoma.
G R Storey, P Davies, R Cooper. Clin Nucl Med 2000
2
50

[A case report of distant lymph nodes metastases from prostate cancer imaged with 201Tl and 99mTc-MIBI].
Katsuji Ikekubo, Megumu Hino, Hidetomi Ito, Hiroyuki Ohtsuka, Yasuhiko Saiki. Kaku Igaku 2003
1
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.